Cargando…
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is caused by abnormal accumulation of lipids within liver cells. Its prevalence is increasing in developed countries in association with obesity, and it represents a risk factor for non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellul...
Autores principales: | Jiménez-Agüero, Raúl, Emparanza, José I, Beguiristain, Adolfo, Bujanda, Luis, Alustiza, José M, García, Elisabeth, Hijona, Elizabeth, Gallego, Lander, Sánchez-González, Javier, Perugorria, María J, Asensio, José I, Larburu, Santiago, Garmendia, Maddi, Larzabal, Mikel, Portillo, María P, Aguirre, Leixuri, Banales, Jesús M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145227/ https://www.ncbi.nlm.nih.gov/pubmed/25164060 http://dx.doi.org/10.1186/s12916-014-0137-y |
Ejemplares similares
-
Effect of pravastatin on the survival of patients with advanced gastric cancer
por: Bujanda, Luis, et al.
Publicado: (2015) -
Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats
por: Aguirre, Leixuri, et al.
Publicado: (2019) -
Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010) -
Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
por: Hijona, Elizabeth, et al.
Publicado: (2012) -
Quantification of iron concentration in the liver by MRI
por: Alústiza Echeverría, José María, et al.
Publicado: (2011)